Michael H. Davidson to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Michael H. Davidson has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.073
-
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients. Cancer Chemother Pharmacol. 2016 Feb; 77(2):375-83.
Score: 0.073